Abstract:Ligand activation of fibroblast growth factor receptor-1 (FGFR-1) induces an angiogenic response following activation of multiple intracellular signaling substrates, including the Src family of nonreceptor tyrosine kinases (SFK). However, the direct association between FGFR-1 and SFK and the involvement of SFK in FGFR-1-dependent cell proliferation have been controversial. Structural variants of FGFR-1 are generated by alternative splicing which results in two major isoforms, containing either three (FGFR-1α) or two (FGFR-1β) immunoglobulin-like domains in the extracellular region. To determine whether alternatively spliced FGFR-1 isoforms differentially activate SFK, we have examined FGF receptor-negative endothelial cells stably transfected with human cDNA encoding either FGFR-1α or FGFR-1β. Transient activation of c-YES, the predominant SFK expressed in these endothelial cells, was restricted to FGFR-1β transfectants following exposure to acidic fibroblast growth factor (FGF-1). Co-immunoprecipitation studies revealed that c-YES directly associated with FGFR-1β. The Src homology (SH)2 domain (and not the SH3 domain) of c-YES was able to recognize tyrosine phosphorylated FGFR-1β. FGFR-1β-specific activation of c-YES was accompanied by its association with and activation of cortactin. FGF-1 treatment of both FGFR-1α and FGFR-1β transfectants induced SFK-independent cellular proliferation and growth in low density cultures. At high density, under both anchorage-dependent and -independent conditions, FGF-1 failed to induce proliferation and growth of FGFR-1α transfectants. In contrast, FGF-1 induced proliferation, growth, and formation of cord-like structures in high density cultures of FGFR-1β transfectants in an SFK-dependent manner. In vitro cord formation on Matrigel was restricted to FGFR-1β transfectants in an SFK-dependent manner. Formation of vascular structures in vivo was limited to endothelial cells transfected with FGFR-1β. Collectively, these results emphasize the roles of alternatively spliced FGFR-1 structural isoforms and activation of SFK as modulators of endothelial cell growth during the formation of neovascular structures.

Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs

Solution structure of human acidic fibroblast growth factor and interaction with heparin-derived hexasaccharide

Surface plasmon resonance analysis to evaluate the importance of heparin sulfate groups' binding with human aFGF and bFGF

Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes.

Molecular modeling and deletion mutagenesis implicate the nuclear translocation sequence in structural integrity of fibroblast growth factor-1

Heparan Sulfate Domains Required for Fibroblast Growth Factor 1 and 2 Signaling Through Fibroblast Growth Factor Receptor 1C*

Fibroblast Growth Factor-Based Signaling Through Synthetic Heparan Sulfate Blocks Copolymers Studied Using High Cell Density Three-Dimensional Cell Printing*

Primer on fibroblast growth factor 7 (FGF 7)

Receptor Specificity of the Fibroblast Growth Factor Family - the Complete Mammalian Fgf Family

The Structure of a Ca2+-binding Epidermal Growth Factor-Like Domain: Its Role in Protein-Protein Interactions

Molecular Dynamics Simulations and Functional Characterization of the Interactions of the PAR2 Ectodomain with Factor VIIa

Structure Of Pleiotrophin- And Hepatocyte Growth Factor-Binding Sulfated Hexasaccharide Determined By Biochemical And Computational Approaches

Disulfide bridge-dependent dimerization triggers FGF2 membrane translocation into the extracellular space

Sulfated polysaccharides interact with fibroblast growth factors and protect from denaturation

Sulfonated Copolymers as Heparin-Mimicking Stabilizer of Fibroblast Growth Factor: Size, Architecture, and Monomer Distribution Effects

Interaction of heparin with human basic fibroblast growth factor: Protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan

Modulation of Wound Repair by Members of the Fibroblast Growth Factor Family

Differential effects of the N‐terminal helix of FGF8b on the activity of a small‐molecule FGFR inhibitor in cell culture and for the extracellular domain of FGFR3c in solution

Alternatively Spliced FGFR-1 Isoforms Differentially Modulate Endothelial Cell Activation of C-Yes

The role of fibroblast growth factor 7 in cartilage development and diseases